Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
FDA safety update – Prolia® (denosumab)
January 19, 2024 - The FDA announced the addition of a Boxed Warning to the Prolia (denosumab) drug label regarding the risk of severe hypocalcemia in patients with advanced chronic kidney disease (CKD).
